This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory medicine shortage

UK Co-codamol Shortage Until June 2026

Analysis based on 9 articles · First reported Jan 29, 2026 · Last updated Feb 13, 2026

Sentiment
-50
Attention
4
Articles
9
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The co-codamol shortage in the United Kingdom negatively impacts the pharmaceutical and healthcare sectors, potentially leading to increased demand for alternative painkillers and putting pressure on the United Kingdom===National Health Service. This event highlights vulnerabilities in the medicine supply chain, which could affect investor confidence in related industries.

Pharmaceuticals Healthcare

The United Kingdom is experiencing a severe national shortage of co-codamol, a painkiller relied upon by millions. The shortage primarily affects 30mg/500mg tablets and is expected to last until at least June 2026. The National Pharmacy Association has reported that pharmacies are struggling to obtain supplies and are assisting 'distressed patients.' NHS trusts, including United Kingdom===NHS Grampian, have confirmed the issue and are advising patients on alternative pain relief options like paracetamol. The United Kingdom===Department of Health and Social Care has added co-codamol to a list of medicines that cannot be hoarded or exported from the United Kingdom and has issued guidance to healthcare professionals not to initiate new patients on the drug. Olivier Picard, Chair of the National Pharmacy Association, has called for urgent government action to address the growing list of medicine shortages and improve the medicine supply system.

80 National Pharmacy Association notified of supply disruption until June 2026
75 United Kingdom===National Health Service flagged supply issues of co-codamol
70 United Kingdom===Department of Health and Social Care added co-codamol to list of medicines not to be hoarded or exported
60 Olivier Picard called for government action on medicine shortages United Kingdom===Department of Health and Social Care
govactor
The United Kingdom===National Health Service (NHS) is experiencing a national shortage of co-codamol, impacting its ability to provide this painkiller to patients across the United Kingdom. NHS trusts, such as United Kingdom===NHS Grampian, have confirmed the shortage and are advising patients on alternative options.
Importance 80 Sentiment -40
ngo
The National Pharmacy Association has been informed about the co-codamol shortage and is actively communicating the issue, advocating for government action, and supporting pharmacists in managing distressed patients.
Importance 70 Sentiment -30
cnt
The United Kingdom is grappling with a critical national shortage of co-codamol, affecting millions of its citizens and highlighting broader issues within its medicine supply system.
Importance 70 Sentiment -20
govactor
The United Kingdom===Department of Health and Social Care (DoH) has acknowledged the co-codamol shortage by adding it to the list of medicines that cannot be hoarded or exported from the United Kingdom. They have also issued guidance to healthcare professionals regarding the supply constraints.
Importance 60 Sentiment -30
govactor
United Kingdom===NHS Grampian has confirmed the UK-wide shortage of co-codamol 30/500 tablets and is informing its patients about limited supplies and alternative pain relief options.
Importance 40 Sentiment -30
per
Olivier Picard, Chair of the National Pharmacy Association, has voiced concerns about the distressing shortage and called for urgent government action to address medicine supply issues.
Importance 30 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.